{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T12:54:30Z","timestamp":1740142470100,"version":"3.37.3"},"reference-count":25,"publisher":"FapUNIFESP (SciELO)","issue":"4","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Braz. Dent. J."],"abstract":"<jats:p>Abstract Hand-foot syndrome (HFS) is a common adverse effect of anticancer therapy. It is known to cause dermatological symptoms including acral erythema and dysesthesia of the palms and soles of the feet, swelling, pain, itching, and scaling. Some drugs, like capecitabine, are known to trigger this condition. However, pigmentation of the oral mucosa is a rare adverse effect. This study aims to report a case of oral mucosa hyperpigmentation caused by capecitabine therapy before the clinical diagnosis of HFS. A 58-year-old female, diagnosed with invasive breast duct carcinoma, had the central nervous system, liver, skin, and lung metastasis, using capecitabine every day for 14 cycles. Oral examination revealed multifocal black macules on the hard palate, bilateral buccal mucosa, gingival mucosa, and dorsum of the tongue. The clinical hypothesis was oral mucosa hyperpigmentation by capecitabine use and only periodic follow-up was necessary. Hyperpigmentation of oral mucosa by capecitabine is a rare consequence of neoplastic therapy and your association with HFS is unclear, and poorly reported. The report of these events is important to alert oncology health teams about the individual tolerance to capecitabine therapy.<\/jats:p>","DOI":"10.1590\/0103-6440202204711","type":"journal-article","created":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T09:13:36Z","timestamp":1661764416000},"page":"97-102","source":"Crossref","is-referenced-by-count":1,"title":["Oral hyperpigmentation as an initial clinical aspect of hand foot syndrome"],"prefix":"10.1590","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8642-3834","authenticated-orcid":false,"given":"\u00c9der Gerardo dos","family":"Santos-Leite","sequence":"first","affiliation":[{"name":"University of Campinas,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2625-045X","authenticated-orcid":false,"given":"Lorena Vieira","family":"Sacramento","sequence":"additional","affiliation":[{"name":"Federal University of Bahia,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7707-484X","authenticated-orcid":false,"given":"Alessandra Monteiro","family":"Santana","sequence":"additional","affiliation":[{"name":"Federal University of Bahia,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9798-9016","authenticated-orcid":false,"given":"Juliana Borges de Lima","family":"Dantas","sequence":"additional","affiliation":[{"name":"Federal University of Bahia,  Brazil; Bahiana School of Medicine and Public Health,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3711-5835","authenticated-orcid":false,"given":"Manoela","family":"Carrera","sequence":"additional","affiliation":[{"name":"State University of Bahia,  Brazil; Federal University of Bahia,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0917-4598","authenticated-orcid":false,"given":"Gabriela Botelho","family":"Martins","sequence":"additional","affiliation":[{"name":"Federal University of Bahia,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2022,8]]},"reference":[{"issue":"5","key":"ref1","doi-asserted-by":"crossref","DOI":"10.1007\/s11095-020-02828-6","article-title":"Phase I pharmacological study of continuous chronomodulated capecitabine treatment","volume":"37","author":"Roosendaal J","year":"2020","journal-title":"Pharm Res"},{"issue":"6","key":"ref2","first-page":"692","article-title":"Efficacy of capecitabine-based combination therapy and single-agent capecitabine maintenance therapy in patients with metastatic breast cancer","volume":"26","author":"Lv H","year":"2014","journal-title":"Chinese J Cancer Res"},{"issue":"5","key":"ref3","doi-asserted-by":"crossref","first-page":"326","DOI":"10.4103\/0253-7613.70401","article-title":"An unusual case of capecitabine hyperpigmentation: Is hyperpigmentation a part of hand-foot syndrome or a separate entity","volume":"42","author":"Vasudevan B","year":"2010","journal-title":"Indian J Pharmacol"},{"issue":"3","key":"ref4","article-title":"Hyperpigmentation with Capecitabine: Part of Hand-Foot Syndrome or a Separate Entity?","volume":"10","author":"Caprez J","year":"2018","journal-title":"Cureus"},{"issue":"5","key":"ref5","doi-asserted-by":"crossref","first-page":"427","DOI":"10.4103\/0378-6323.140302","article-title":"Hand and foot syndrome secondary to capecitabine","volume":"80","author":"Lal HS","year":"2014","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"10","key":"ref6","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1111\/j.1468-3083.2007.02242.x","article-title":"Capecitabine-induced hand-foot syndrome and cutaneous hyperpigmentation in an elderly vitiligo patient [18]","volume":"21","author":"Tavares-Bello R","year":"2007","journal-title":"J Eur Acad Dermatology Venereol"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.annder.2011.06.012","article-title":"Hyperpigmentation \u00e0 la capecitabine suivie de syndrome mains-pieds: Une nouvelle observation","volume":"139","author":"Agharbi FZ","year":"2012","journal-title":"Ann Dermatol Venereol"},{"issue":"1","key":"ref8","first-page":"1","article-title":"Pigmented Lesions of Buccal and Labial Mucosa in a Patient Treated by Capecitabine (Xeloda): A Case Report","volume":"1","author":"Becker T","year":"2015","journal-title":"Int J Dent Oral Heal"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3904\/kjim.2007.22.2.109","article-title":"Hand-foot syndrome with scleroderma-like change induced by the oral capecitabine: A case report","volume":"22","author":"Lee SD","year":"2007","journal-title":"Korean J Intern Med"},{"issue":"10","key":"ref10","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1021\/acs.chemrestox.6b00215","article-title":"Possible Pathways of Capecitabine-Induced Hand-Foot Syndrome","volume":"29","author":"Lou Y","year":"2016","journal-title":"Chem Res Toxicol"},{"issue":"11","key":"ref11","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1001\/jamaoncol.2017.1269","article-title":"Predictors of hand-foot syndrome and pyridoxine for prevention of capecitabine-induced hand-foot syndrome a randomized clinical trial","volume":"3","author":"Yap YS","year":"2017","journal-title":"JAMA Oncol"},{"issue":"12","key":"ref12","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1080\/14740338.2016.1238067","article-title":"Incidence and implications of chemotherapy related hand-foot syndrome","volume":"15","author":"Nikolaou V","year":"2016","journal-title":"Expert Opin Drug Saf"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.jaad.2014.03.019","article-title":"Chemotherapy-induced hand-foot syndrome and nail changes: A review of clinical presentation, etiology, pathogenesis, and management","volume":"71","author":"Miller KK","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"ref14","doi-asserted-by":"crossref","first-page":"301","DOI":"10.4103\/0019-5154.55651","article-title":"Hand-foot syndrome due to capecitabine","volume":"54","author":"Surjushe A","year":"2009","journal-title":"Indian J Dermatol"},{"key":"ref15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejon.2004.06.007","article-title":"Management of hand-foot syndrome in patients treated with capecitabine (Xeloda\u00ae)","volume":"8","author":"Lassere Y","year":"2004","journal-title":"Eur J Oncol Nurs"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1081\/CNV-120000360","article-title":"Incidence and severity of hand-foot syndrome in colorectal cancer patients treated with capecitabine: A single-institution experience","volume":"20","author":"Abushullaih S","year":"2002","journal-title":"Cancer Invest"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.mjafi.2012.01.009","article-title":"Capecitabine induced hand-foot syndrome: Report of two cases","volume":"69","author":"Sanghi S","year":"2013","journal-title":"Med J Armed Forces India"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.clcc.2011.05.004","article-title":"Unilateral hand-foot syndrome: Does it take sides? Case report and literature review","volume":"11","author":"Da Cruz LA","year":"2012","journal-title":"Clin Colorectal Cancer"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.etap.2016.12.001","article-title":"The contribution of keratinocytes in capecitabine-stimulated hand-foot-syndrome","volume":"49","author":"Chen M","year":"2017","journal-title":"Environ Toxicol Pharmacol"},{"issue":"2","key":"ref20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.5826\/dpc.0502a14","article-title":"Benign dermoscopic parallel ridge pattern in plantar hyperpigmentation due to capecitabine","volume":"5","author":"Tognetti L","year":"2015","journal-title":"Dermatol Pract Concept"},{"issue":"2","key":"ref21","first-page":"101","article-title":"Serious hand-and-foot syndrome in black patients treated with capecitabine: Report of 3 cases and review of the literature","volume":"73","author":"Narasimhan P","year":"2004","journal-title":"Cutis"},{"issue":"1-4","key":"ref22","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s12029-009-9068-9","article-title":"Palmar-plantar hyperpigmentation with capecitabine in adjuvant colon cancer","volume":"39","author":"Vickers MM","year":"2008","journal-title":"J Gastrointest Cancer"},{"issue":"2","key":"ref23","article-title":"S\u00edndrome M\u00e3o-P\u00e9 Induzida por Quimioterapia: Abordagem Cl\u00ednica e Epidemiol\u00f3gica de Pacientes com C\u00e2ncer","volume":"65","author":"Costa J dos S","year":"2019","journal-title":"Rev Bras Cancerol"},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","DOI":"10.1016\/j.oooo.2017.10.006","article-title":"Drug-associated hyperpigmentation of the oral mucosa: report of four cases","volume":"125","author":"Tosios KI","year":"2018","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"6","key":"ref25","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.tripleo.2003.11.006","article-title":"Oral mucosal pigmentation secondary to minocycline therapy: Report of two cases and a review of the literature","volume":"97","author":"Treister NS","year":"2004","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"}],"container-title":["Brazilian Dental Journal"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0103-64402022000400097&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T09:13:58Z","timestamp":1661764438000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0103-64402022000400097&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":25,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,8]]}},"alternative-id":["S0103-64402022000400097"],"URL":"https:\/\/doi.org\/10.1590\/0103-6440202204711","relation":{},"ISSN":["1806-4760","0103-6440"],"issn-type":[{"type":"electronic","value":"1806-4760"},{"type":"print","value":"0103-6440"}],"subject":[],"published":{"date-parts":[[2022,8]]}}}